Goodly Innovations uses augmented reality (AR) in its Optiworx system to digitize complex processes and documentation tasks and thus save costs. Its target markets are the pharmaceutical and biopharmaceutical industries.
Optiworx visually guides employees through complex changeover, maintenance, and production processes. This significantly reduces downtime and individual errors. Teams of any size can work synchronously on a complex task simultaneously and in real time. The system can be quickly integrated into virtually any production environment.
The Munich companies was founded in 2016 by Dirk Schrader and Robert Hoffmeister. CEO Dirk Schrader says:
"We are seeing significant interest in our unique system from leading international companies. The Series A Plus round will enable us to leverage this momentum and establish our technology as an international standard by increasing investment in our development capabilities and sales team. We thank our investors and look forward to our continued successful collaboration."
“Goodly Innovations fills a gap in the market”
It has proven to be a convincing business model to use AR data glasses to visually guide employees to tasks in a concrete way and to support teams of several people in their work in real time, says Alexander Ullmann, Senior Investment Manager at BayBG. The new capital creates the conditions for the further rollout and long-term success of Goodly Innovations.
George Ried, Managing Director of Bayern Kapital, adds:
"Goodly Innovations fills a market gap with Optiworx and has developed excellently since our entry. The scalable Optiworx system offers noticeable efficiency and quality benefits in the pharmaceutical and biotech industries while also relieving staff burdens. Of course, applications in other industries are also conceivable. We remain convinced of the company's long-term growth potential and support Goodly Innovations in its planned steps."
